Cargando…

Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial

Understanding the benefits and risks of treatments to be used by older individuals (≥65 years old) is critical for informed therapeutic decisions. Glucose‐lowering therapy for older patients with diabetes should be tailored to suit their clinical condition, comorbidities and impaired functional stat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinclair, Alan J., Heller, Simon R., Pratley, Richard E., Duan, Ran, Heine, Robert J., Festa, Andreas, Kiljański, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383926/ https://www.ncbi.nlm.nih.gov/pubmed/32100382 http://dx.doi.org/10.1111/dom.14013

Ejemplares similares

Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM)
por: Heller, Simon R., et al.
Publicado: (2017)

Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus
por: Pratley, Richard E., et al.
Publicado: (2018)

Das string-imperium schlägt zurück
por: Grotelüschen, Frank
Publicado: (2007)

Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Boye, Kristina S., et al.
Publicado: (2021)

Management of Type 2 Diabetes in Older People
por: Abdelhafiz, Ahmed H., et al.
Publicado: (2013)

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
por: Simó, Rafael, et al.
Publicado: (2015)

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
por: Perez-Nieves, Magaly, et al.
Publicado: (2018)

Multimorbidity, Frailty and Diabetes in Older People–Identifying Interrelationships and Outcomes
por: Sinclair, Alan J., et al.
Publicado: (2022)

Use of short-acting insulin aspart in managing older people with diabetes
por: Marouf, Eltayeb, et al.
Publicado: (2009)

Targets for Body Fat, Blood Pressure, Lipids, and Glucose-Lowering Interventions in Healthy Older People
por: Tsigos, Constantine, et al.
Publicado: (2013)

The influence of cognition on self-management of type 2 diabetes in older people
por: Tomlin, Ali, et al.
Publicado: (2016)

Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose
por: Anderson, Richard A., et al.
Publicado: (2015)

The effect of frailty should be considered in the management plan of older people with Type 2 diabetes
por: Abdelhafiz, Ahmed H, et al.
Publicado: (2016)

Metabolic Characteristics of Frail Older People with Diabetes Mellitus—A Systematic Search for Phenotypes
por: Abdelhafiz, Ahmed H., et al.
Publicado: (2023)

Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self‐titrating insulin glargine U‐100
por: Hollander, Priscilla A., et al.
Publicado: (2019)

Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus—a choice determined by metabolic phenotype
por: Sinclair, Alan J., et al.
Publicado: (2022)

Linagliptin use in older individuals with type 2 diabetes
por: Pratley, Richard E
Publicado: (2014)

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV
por: Dagogo‐Jack, Samuel, et al.
Publicado: (2022)

Rural older people had lower mortality after accidental falls than non-rural older people
por: Huang, Jen-Wu, et al.
Publicado: (2017)

Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
por: Hirose, Takahisa, et al.
Publicado: (2019)

Social Disadvantage Is Associated With Lower Vitamin D Levels in Older People and There Is No Surrogate for Its Measurement
por: Heald, Adrian H., et al.
Publicado: (2017)

Oral Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses
por: Pratley, Richard E., et al.
Publicado: (2021)

Why does COVID-19 disproportionately affect older people?
por: Mueller, Amber L., et al.
Publicado: (2020)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

The Association between Glucose Control and Functional Indices in Older People with Diabetes
por: Azmon, M., et al.
Publicado: (2018)

POOR GLUCOSE REGULATION IS ASSOCIATED WITH LOWER WELL-BEING AMONG OLDER MEN, BUT NOT WOMEN
por: Mantantzis, Konstantinos, et al.
Publicado: (2019)

Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
por: Doucet, Jean, et al.
Publicado: (2023)

Glucose regulation and physical performance among older people: the Helsinki Birth Cohort Study
por: Åström, Max J., et al.
Publicado: (2018)

Optimal management of older people with frailty non-weight bearing after lower limb fracture: a scoping review
por: Aloraibi, Saleh, et al.
Publicado: (2021)

Triglyceride–Glucose Index as a Potential Indicator of Sarcopenic Obesity in Older People
por: Kim, Bokun, et al.
Publicado: (2023)

Rapid review of decision-making for place of care and death in older people: lessons for COVID-19
por: West, Emily, et al.
Publicado: (2020)

Rapid review of decision-making for place of care and death in older people: Lessons for COVID-19
por: West, E., et al.
Publicado: (2021)

Evaluating the social fitness Programme for older people with cognitive problems and their caregivers: lessons learned from a failed trial
por: Donkers, H W, et al.
Publicado: (2018)

362 Group Model Building to characterize the experiences of older adults with type 1 diabetes (T1D) with continuous glucose monitoring (CGM) therapy and uncover suboptimal response patterns
por: Kahkoska, Anna R, et al.
Publicado: (2022)

FRAILTY AND THE EFFECTIVENESS AND SAFETY OF NEW GLUCOSE-LOWERING DRUGS IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019)

UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS WITH AND WITHOUT DEMENTIA
por: Gopalakrishnan, Chandrasekar, et al.
Publicado: (2022)

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes
por: Gordon, Jason, et al.
Publicado: (2017)

Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)

Poor Lower Extremity Function Was Associated with Pre-Diabetes and Diabetes in Older Chinese People
por: Zhang, Wen, et al.
Publicado: (2014)

Subjective health in older people
por: Gunzelmann, Thomas, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_mhmahjksqfpfarj2e7gpjajre0